Catalyst Wire Dossier Catalyst Wire Dossier

EDIT-B Test

RNA-editing blood biomarker diagnostic assay for differential diagnosis of bipolar disorder · Alcediag
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EDIT-B Test, covering 2024-12-17 to 2024-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers

See pricing